Myconostica announces successful continuation of D round with investment by Medac
19 July 2010
Myconostica Ltd, the UK-based medical diagnostic company developing and commercialising rapid and highly specific tests for life-threatening fungal infections, today announces the completion of an investment by medac Gesellschaft fuer klinische Spezialpraeparate mbH.
This investment, a continuation of Myconostica’s series D round which had a first close in late 2009, will be used to further develop Myconostica’s pipeline of products along with marketing the company’s existing suite of diagnostic tests.
Medac is an established and successful privately-held German pharmaceutical company with a growing pharmaceutical business and a diagnostics division, which acts as exclusive distributor of Myconostica’s products in Germany. Dr Rainer Dickhardt, Managing Director of Medac’s diagnostic business, joins Myconostica’s board, and brings many years of experience in pharmaceuticals and diagnostics.
Any further questions, please do not hesitate to call me.
James Milton
Associate Director
Cardew Group
12 Suffolk St
London SW1Y 4HG
Tel: 0207 930 0777
Mob: 07867 548 506
www.cardewgroup.com
|